Back to News
Market Impact: 0.32
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
Source: GlobeNewswire
Private Markets & VentureCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
Celularity closed an initial $10 million financing as part of a recapitalization that could raise up to $28 million. The company said the capital supports its growth plans and targets positive operating cash flow by Q1 2027, improving its funding runway but leaving execution and future financing dependent on achieving that target.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
CELU0.55
More News
- Exclusive: AJ Scaramucci comes out of stealth with a $350 million bet on ‘Programmable Reality’
- Oracle Japan shares surge 7% after record fiscal first quarter, bucking selloff of U.S. parent
- Akamai secures $11.6B cloud deal with Anthropic for AI workloads
- Costco makes progress on a key membership metric. Here's our new price target on the stock
- Here’s the Tesla Semi… again
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Document Search Enhancements, AI Enhancements, AI Actions, & Chat Export
- AI Vendor Landscape for Institutional Investment Teams